Skip to main content
OpenTrials
Completed

NCT Number: NCT03956043

Diagnostic Accuracy in Sepsis

The sepsis syndrome has recently been more stringently defined as "a life-threatening organ dysfunction caused by a dysregulated host response to infection". Clinical and paraclinical tools are investigated for their ability to adequately recognize sepsis early.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Oslo University Hospital

Oslo, Norway

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients >18 years old with suspected sepsis in the Emergency Department of Oslo University Hospital Oslo

Exclusion criteria

  • Non

Treatment and study plan

Primary outcomes

  1. Diagnostic accuracy in sepsis

    Time frame: within 90 days after inclusion

    Sensitivity, specificity, predictive values, AUC of clinical criteria of sepsis in the Emergency department, compared to post hoc assesment

  2. Prognostic accuracy in sepsis

    Time frame: 90 days after inclusion

    Sensitivity, specificity, predictive values, AUC of clinical criteria of sepsis in the Emergency department, compared to in hospital, 30 and 90 days mortality

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Registry information

Official study title

Diagnostic Accuracy of Clinical and Paraclinical Tools in Sepsis

Important dates

Study start
2017
Primary completion
2024
Study completion
2024
First posted
May 20, 2019
Registry last updated
Mar 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.